Press Releases

Parkinson’s UK is named BIA Charity of the Year for 2018

The BioIndustry Association (BIA) has today announced that Parkinson’s UK will be its official Charity of the Year for 2018. The partnership will be formally launched at the upcoming BIA Gala Dinner on 25 January 2018.

Life science coalition launches a joint policy document on the potential impact of the United Kingdom’s exit from the European Union.

The associations representing the European and British life science industry (AESGP, ABPI, BIA, BGMA, EBE, EFPIA, EUCOPE, EuropaBio, Medicines for Europe, PAGB, Vaccines Europe) have today launched a joint policy document on the potential impact of the United Kingdom’s exit the European Union.

“Safeguarding public health must be number one priority” for EU27 and UK Government in phase two of Brexit talks

To coincide with today’s House of Commons Health Select Committee on ‘Brexit: the regulation of medicines, medical devices and substances of human origin’, the Association of the British Pharmaceutical Industry (ABPI) and the BioIndustry Association (BIA) have published new research on the public health implications of Brexit.

BIA reacts to announcement from European Commission President Jean-Claude Juncker and Prime Minister Theresa May that ‘sufficient progress’ has been agreed on phase one of the Brexit negotiations. 

CEO, Steve Bates, said: “We welcome today’s agreement. It is now crucial that the UK and EU agree a transition period to ensure that the supply of medicines to patients in the UK and across Europe is not affected. Public health and health security should be the first priority for the second phase of talks and we stand ready as a unified life science sector to provide expert input on such a process".


Member News

Dr Sally Ann Forsyth appointed CEO of Stevenage Bioscience Catalyst

Stevenage Bioscience Catalyst (SBC), the open innovation campus driving collaboration to improve healthcare, is pleased to announce that Dr Sally Ann Forsyth is to join as CEO in March 2018. Dr Forsyth, who joins from Norwich Research Park, has driven the development of several leading UK science parks with associated investment of almost £100m. With scientific and financial expertise and as an open innovation practitioner, she will lead SBC through its next phase of expansion.

Medherant completes £3.8 million funding round

Medherant, a leader in next-generation transdermal drug delivery, has raised £3.8 million in its latest funding round. The fundraising was led by majority shareholder Mercia Technologies PLC, with the balance coming from other existing shareholders as well as new private investors. This latest investment will support the company as it progresses its ibuprofen TEPI Patch® into clinical development in early 2018.

Tissue Science and Regenerative Medicine

9th International Conference on Tissue Science and Regenerative Medicine is mainly based on the theme “Exploring the frontiers in tissue science and Medicine’’ We warmly welcome all the participants of world’s leading Scientists, Researchers and Scholars. We provide a platform for young researchers and students to present their research through oral presentations through which they can develop a foundation for collaboration among young researchers.

Arecor announces successful vaccine stabilising formulation technology to more effectively combat two major diseases of livestock in the developing world

Cambridge, UK., 8th December 2017: Arecor Ltd (“the Company”), a leader in developing superior biopharmaceuticals through the application of an innovative formulation technology platform, ArestatTM, is pleased to announce that the Company, in partnership with, GALVmed (, has successfully applied its vaccine formulation technology to stabilise liquid formulations of vaccines to combat two major diseases of livestock in the developing world.


BIA blog

Video of the Week: European Biotech Week 2017 - Interview with Geert Angenon

The European Biotech Week had never reached so many people on the European continent. Between 25 September and 1 October 2017, a record 19 European countries witnessed more than 150 biotech-focused activities and events on their territories. On this special occasion, Geert Angenon, Professor of Plant Biotechnology at Vrije Universiteit Brussel, took the floor to share his views on GMOs and other green biotech applications.

Brexit and Trade – Implications for the Life Sciences Sector

Hardly talked about before the EU referendum, trade has become an increasingly hot topic ever since. With EU leaders expected to formally decide that the Brexit negotiations will move to discuss the UK-EU future trading relationship (“Phase II”) at the end of the week, this month is no different. Meanwhile, the UK government is getting ready to transition from the EU’s common commercial policy to its own independent trade policy through the Trade Bill, which is currently progressing through Parliament.

CEO Update: Monday 11 December

Last week, we saw the release of the highly anticipated Life Sciences Sector Deal from government, and it was fantastic to see that ours is the first sector to have a deal published – a clear recognition of our industry’s importance to the future growth and prosperity of the country.

Video of the Week: How does the NHS in England work? An alternative guide

As part of their 'An alternative guide' series, the King's Fund have produced a handy and easy to understand animation on the NHS in England. This short video is a whistle-stop tour of how the NHS works in 2017 and how it’s changing.


Our publications

Influencing and shaping our sector, BIA update: July – October 2017

his quarterly update gives an overview of key policy developments and the BIA’s continued engagement with policymakers, regulatory authorities and wider stakeholders on behalf of the UK life sciences industry, from July to October 2017. Brexit, the government’s Industrial Strategy and a potential sector deal have been keeping all of us at the BIA very busy this quarter.

Growing the next generation of UK management talent

BIA directory of industry training opportunities to help build the next generation of management talent.

A vision for the UK life sciences sector in 2025

This vision, developed in consultation with the BIA Board and sector experts, sets out an ambitious goal for the UK to become a top global cluster in life sciences by 2025.